Skip to content

Hemab Therapeutics Holdings

US · COAG #3007 by market cap Listed 2026
39.29 -0.57 -1.43%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

About Hemab Therapeutics Holdings

Hemab Therapeutics Holdings, Inc. operates as a clinical-stage biotechnology company. It engages in developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience. The company was founded in 2020 and is headquartered in Cambridge, MA.

Founded
2020
CEO
Mr. Benny Sorensen, M.D.,PhD
Employees
72
Headquarters
Cambridge, Massachusetts, United States of America
Fiscal year end
12-31
Website
hemab.com

Company profile

Exchange
US
Symbol
COAG
Market-cap rank
#3007
Listing date
2026-05-01
Market cap
1.84B
Float cap
835.96M
Shares out
46.73M
Float shares
21.28M

Sectors & themes

Biotechnology IPOs

Browse all sectors & themes

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Hemab Therapeutics Holdings discussion 0 comments

Add a comment